PHARMACOLOGY, ELECTROPHYSIOLOGY, AND PHARMACOKINETICS OF MEXILETINE

被引:67
作者
WOOSLEY, RL
WANG, T
STONE, W
SIDDOWAY, L
THOMPSON, K
DUFF, HJ
CERSKUS, I
RODEN, D
机构
[1] VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,NASHVILLE,TN 37232
[2] VANDERBILT UNIV,MED CTR,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232
关键词
D O I
10.1016/0002-8703(84)90175-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1058 / 1065
页数:8
相关论文
共 41 条
[1]  
ALLEN JD, 1977, POSTGRAD MED J, V53, P35
[2]   EFFECT OF KO 1173, A NEW ANTICONVULSANT AGENT ON EXPERIMENTAL CARDIAC-ARRHYTHMIAS [J].
ALLEN, JD ;
SHANKS, RG ;
ZAIDI, SA ;
KOFIEKUE, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 45 (04) :561-&
[3]  
BAUDINET G, 1980, ACTA CARDIOL, V25, P55
[4]  
BECKETT AH, 1977, POSTGRAD MED J, V53, P60
[5]   ENHANCED METABOLISM OF MEXILETINE AFTER PHENYTOIN ADMINISTRATION [J].
BEGG, EJ ;
CHINWAH, PM ;
WEBB, C ;
DAY, RO ;
WADE, DN .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) :219-223
[6]   THERAPEUTIC DRUG-MONITORING OF ANTIARRHYTHMIC AGENTS [J].
BROWN, JE ;
SHAND, DG .
CLINICAL PHARMACOKINETICS, 1982, 7 (02) :125-148
[7]  
BURKE GH, 1982, CIRCULATION, V66, P292
[8]  
CAMPBELL NPS, 1978, BRIT J CLIN PHARMACO, V6, P103, DOI 10.1111/j.1365-2125.1978.tb00833.x
[9]   RESTING AND RATE-DEPENDENT DEPRESSION OF MAXIMUM RATE OF DEPOLARIZATION (VMAX) IN GUINEA-PIG VENTRICULAR ACTION-POTENTIALS BY MEXILETINE, DISOPYRAMIDE, AND ENCAINIDE [J].
CAMPBELL, TJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (02) :291-296
[10]   MEXILETINE IN THE TREATMENT OF RESISTANT VENTRICULAR ARRHYTHMIAS - ENHANCEMENT OF EFFICACY AND REDUCTION OF DOSE-RELATED SIDE-EFFECTS BY COMBINATION WITH QUINIDINE [J].
DUFF, HJ ;
RODEN, D ;
PRIMM, RK ;
OATES, JA ;
WOOSLEY, RL .
CIRCULATION, 1983, 67 (05) :1124-1128